Form D/A - Notice of Exempt Offering of Securities: [Amend]
SEC Accession No. 0001835848-22-000001
Filing Date
2022-12-01
Accepted
2022-12-01 10:06:27
Documents
1
Effectiveness Date
2022-12-01
Items
Item 06b:
Item 3C: Investment Company Act Section 3(c)
Item 3C.1: Section 3(c)(1)

Document Format Files

Seq Description Document Type Size
1 primary_doc.html D/A  
1 primary_doc.xml D/A 8750
  Complete submission text file 0001835848-22-000001.txt   9926
Mailing Address 16 LAUREL AVENUE SUITE 150 WELLESLEY MA 02481
Business Address 16 LAUREL AVENUE SUITE 150 WELLESLEY MA 02481 7814892105
BIOVENTURES INVESTORS MEDTECH GROWTH CAPITAL, LP (Filer) CIK: 0001835848 (see all company filings)

EIN.: 854176772 | State of Incorp.: DE | Fiscal Year End: 1231
Type: D/A | Act: 33 | File No.: 021-383341 | Film No.: 221437687